PureHealth Research LLC – Trademark Portfolio
Entity Type: 16
PureHealth Research LLC holds 56 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 52 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 41 trademarks are registered and 2 are pending. Notable registered marks include CURBFIT, EXUBERANT, PARABROOM, EVERY BEAT, and IMPROBIOME. The owner is based in Cheyenne, WY.
1712 Pioneer Ave, Suite 500
Cheyenne, WY 82001
Showing of trademarks Trademarks
Trademark Classifications
PureHealth Research LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does PureHealth Research LLC have?
PureHealth Research LLC has 56 U.S. trademarks filed with the USPTO. Of these, 41 registered, 2 pending, 13 abandoned.
What trademark classes does PureHealth Research LLC file in?
PureHealth Research LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are PureHealth Research LLC's most well-known trademarks?
PureHealth Research LLC's registered trademark portfolio includes well-known marks such as CURBFIT, EXUBERANT, PARABROOM, EVERY BEAT, and IMPROBIOME. These are among 41 currently registered trademarks in the portfolio.
What is PureHealth Research LLC's trademark registration success rate?
PureHealth Research LLC has a 76% trademark registration rate, with 41 out of 54 resolved applications resulting in successful registration. Currently, 2 applications are pending review.